Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 496
Filter
1.
Bioengineered ; 12(1): 2480-2498, 2021 12.
Article in English | MEDLINE | ID: mdl-34115556

ABSTRACT

High production costs still hamper fast expansion of commercial production of polyhydroxyalkanoates (PHAs). This problem is greatly related to the cultivation medium which accounts for up to 50% of the whole process costs. The aim of this research work was to evaluate the potential of using volatile fatty acids (VFAs), derived from acidogenic fermentation of food waste, as inexpensive carbon sources for the production of PHAs through bacterial cultivation. Bacillus megaterium could assimilate glucose, acetic acid, butyric acid, and caproic acid as single carbon sources in synthetic medium with maximum PHAs production yields of 9-11%, on a cell dry weight basis. Single carbon sources were then replaced by a mixture of synthetic VFAs and by a VFAs-rich stream from the acidogenic fermentation of food waste. After 72 h of cultivation, the VFAs were almost fully consumed by the bacterium in both media and PHAs production yields of 9-10%, on cell dry weight basis, were obtained. The usage of VFAs mixture was found to be beneficial for the bacterial growth that tackled the inhibition of propionic acid, iso-butyric acid, and valeric acid when these volatile fatty acids were used as single carbon sources. The extracted PHAs were revealed to be polyhydroxybutyrate (PHB) by characterization methods of Fourier-transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). The obtained results proved the possibility of using VFAs from acidogenic fermentation of food waste as a cheap substrate to reduce the cost of PHAs production.


Subject(s)
Acids/metabolism , Bacillus megaterium/metabolism , Fatty Acids, Volatile/metabolism , Fermentation , Food , Polyhydroxyalkanoates/biosynthesis , Refuse Disposal , Bacillus megaterium/drug effects , Bacillus megaterium/growth & development , Biomass , Calorimetry, Differential Scanning , Fermentation/drug effects , Glucose/pharmacology , Hydrogen-Ion Concentration , Spectroscopy, Fourier Transform Infrared
2.
J Mater Chem B ; 9(6): 1592-1603, 2021 02 14.
Article in English | MEDLINE | ID: mdl-33471014

ABSTRACT

Many coating materials are commercially available to combat microbial infections. However, these coatings are difficult to synthesize, and are mostly composed of toxic chemicals. Lignin is an under-explored natural biopolymer with multifaceted potential. Lignin, with adhesive, UV resistant, and antimicrobial properties, is a suitable candidate to develop coating materials. Here we report a smart method to fabricate a sustainable nanospray coating from lignin which does not require any toxic chemicals or additives during synthesis. Initially, we have developed stable lignin nanospheres in a single step in aqueous medium, which were later utilized as a lignin nanospray (LNSR). The LNSR was characterized by dynamic light scattering, scanning electron microscopy, FTIR and other analytical techniques. This LNSR showed remarkable UV blocking, antioxidant and light-activated antimicrobial properties. Interestingly, for the first time, the LNSR demonstrated photoluminescence, making it useful for bioimaging. Moreover, singlet oxygen generation potential was observed in the LNSR, which could render it useful in phototheranostic applications (i.e. light assisted imaging and photodynamic therapy). Further, the LNSR was directly utilized to fabricate a sustainable coating. The nanospray coating exhibited maximum light-induced cell killing when applied to common microbes as detected by live-dead cell imaging. Taken together, the lignin nanospray coating developed via a direct pathway holds great promise to disinfect microbes in the presence of light.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology , Coated Materials, Biocompatible/pharmacology , Light , Lignin/pharmacology , Nanoparticles/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Bacillus megaterium/drug effects , Coated Materials, Biocompatible/chemical synthesis , Coated Materials, Biocompatible/chemistry , Drug Development , Escherichia coli/drug effects , Lignin/chemical synthesis , Lignin/chemistry , Microbial Sensitivity Tests , Molecular Structure , Particle Size , Photochemotherapy , Surface Properties
3.
Arch Microbiol ; 202(8): 2311-2321, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32564100

ABSTRACT

Methanolic extract of Artemisia pallens (MEAP) (Asteraceae) was explored as greenbiocorrosion inhibitor for mild steel 1010 in 1.5% sodium chloride environment. Bacillus megaterium SKR7 induces the development of biofilm on the metal surface and forms the pitting corrosion. MEAP was showed (25 ppm) optimum inhibition effect of biocorrosion and further corrosion rate was highly reduced (0.3335 mm/year) than the control system (0.009 mm/year). The electrochemical study has supported the results with a higher value of total resistance (34 Ω cm2) when compared to control systems. It reveals the formation of a protective layer on the metal surface and reduces the adsorption of biofilm. This was due to the antimicrobial effect of MEAP. Overall, the results recognized that MEAP used as a green corrosion inhibitor for MS 1010 with 83% inhibition efficiency.


Subject(s)
Artemisia/chemistry , Bacillus megaterium/drug effects , Bacillus megaterium/metabolism , Biofilms/drug effects , Corrosion , Plant Extracts/pharmacology , Steel , Methanol/chemistry
4.
Microb Pathog ; 146: 104248, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32407860

ABSTRACT

Over the past 50 years, fungal natural products have revolutionized medicine, yielding drugs which have enormous therapeutic potential. The aim of this study was to investigate the probable effect of marine fungal natural products on various skin pathogens. Initially, seventy natural extracts obtained from 35 different marine fungal strains were analysed by the agar well diffusion and broth micro dilution assay for their antibacterial action against six human skin pathogens. The minimum inhibitory effects of all active fungal methanolic extracts on targeted pathogens were observed between 90 and 99% at the concentration of 1 mg/mL. The highest activity was recorded by fungal strains belonging to genera Penicillium, Emericellopsis and Simplicillium. Thereafter, possible effects on target bacterial cells were studied by scanning electron microscopy which show significant destruction and structural deformation in the bacterial cell wall. The results of the present study provided good evidence that the studied marine fungi can be a potential source of natural antibacterial agents against skin bacterial pathogens.


Subject(s)
Anti-Bacterial Agents , Ascomycota/metabolism , Bacteria/drug effects , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Antioxidants/metabolism , Antioxidants/pharmacology , Aquatic Organisms/classification , Aquatic Organisms/genetics , Aquatic Organisms/isolation & purification , Aquatic Organisms/metabolism , Ascomycota/classification , Ascomycota/genetics , Ascomycota/isolation & purification , Aspergillus oryzae/genetics , Aspergillus oryzae/isolation & purification , Aspergillus oryzae/metabolism , Bacillus megaterium/drug effects , Bacillus subtilis/drug effects , Bacillus subtilis/ultrastructure , Bacteria/ultrastructure , Biofilms/drug effects , Biological Products/metabolism , Biological Products/pharmacology , Free Radicals/metabolism , Genes, Fungal , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Penicillium chrysogenum/genetics , Penicillium chrysogenum/isolation & purification , Penicillium chrysogenum/metabolism , Phylogeny , Skin/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/ultrastructure
5.
Lett Appl Microbiol ; 70(6): 407-412, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32133659

ABSTRACT

Inactivation of Bacillales and Clostridiales spores is of interest, since some cause food spoilage and human diseases. A recent publication (mSphere 3: e00597-1, 2018) reported that glycerol monolaurate (GML) in a non-aqueous gel (GMLg) effectively killed spores of Bacillus subtilis, Bacillus cereus and Clostridioides difficile, and Bacillus anthracis spores to a lesser extent. We now show that (i) the B. subtilis spores prepared as in the prior work were impure; (ii) if spore viability was measured by diluting spores 1/10 in GMLg, serially diluting incubations 10-fold and spotting aliquots on recovery plates, there was no colony formation from the 1/10 to 1/1000 dilutions due to GMLg carryover, although thorough ethanol washes of incubated spores eliminated this problem and (iii) GMLg did not kill highly purified spores of B. subtilis, B. cereus, Bacillus megaterium and C. difficile in 3-20 h in the conditions used in the recent publication. GMLg also gave no killing of crude B. subtilis spores prepared as in the recent publication in 5 h but gave ~1·5 log killing at 24 h. Thus, GMLg does not appear to be an effective sporicide, although the gel likely inhibits spore germination and could kill spores somewhat upon long incubations. SIGNIFICANCE AND IMPACT OF THE STUDY: Given potential deleterious effects of spores of Bacillales and Clostridiales, there is an ongoing interest in new ways of spore killing. A recent paper (mSphere 3: e00597-1, 2018) reported that glycerol monolaurate (GML) in a non-aqueous gel (GMLg) effectively killed spores of many species. We now find that (i) the Bacillus subtilis spores prepared as in the previous report were impure and (ii) GMLg gave no killing of purified spores of Bacillales and Clostridiales species in ≤5 h under the published conditions. Thus, GMLg is not an effective sporicide, though may prevent spore germination or kill germinated spores.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillales/drug effects , Clostridiales/drug effects , Laurates/pharmacology , Monoglycerides/pharmacology , Spores, Bacterial/drug effects , Spores, Bacterial/growth & development , Bacillales/growth & development , Bacillus cereus/drug effects , Bacillus megaterium/drug effects , Bacillus subtilis/drug effects , Clostridiales/growth & development , Clostridioides difficile/drug effects , Food Microbiology , Gels/pharmacology
6.
Molecules ; 25(5)2020 Feb 25.
Article in English | MEDLINE | ID: mdl-32106569

ABSTRACT

In the present work, tenoxicam (H2Ten) reacted with Mn(II), Co(II), Ni(II), Cu(II) and Zn (II) ions in the presence of 1.10-phenthroline (Phen), forming new mixed ligand metal complexes. The properties of the formed complexes were depicted by elemental analyses, infrared, electronic spectra, proton nuclear magnetic resonance (1H NMR), mass spectrometry, thermogravimetric (TGA) and differential thermogravimetric (DTG) analysis, molar conductance and magnetic moment. IR spectra demonstrated that H2Ten acted as a neutral bidentate ligand, coordinated to the metal ions via the pyridine-N and carbonyl group of the amide moiety, and Phen through the nitrogen atoms. Kinetic thermodynamics parameters activation energy (E*), enthalpy of activation (ΔH*), entropy of activation (ΔS*), Gibbs, free energy (ΔG*) associated to the complexes have been evaluated. Antibacterial screening of the compounds was carried out in vitro against Clavibacter michiganensis, Xanthomonas campestris and Bacillus megaterium. Antifungal activity was performed in vitro against Monilinia fructicola, Penicillium digitatum and Colletotrichum acutatum. The possible phytotoxic effect of the studied compounds was also investigated on Solanum lycopersicum (tomatoes) and Lepidium sativum (garden cress) seeds. The anticancer activity was screened against cell cultures of HCT-116 (human colorectal carcinoma), HepG2 (human hepatocellular carcinoma) and MCF-7 (human breast adenocarcinoma).


Subject(s)
Anti-Bacterial Agents/chemistry , Antifungal Agents/chemistry , Coordination Complexes/chemistry , Piroxicam/analogs & derivatives , Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Bacillus megaterium/drug effects , Cobalt/chemistry , Coordination Complexes/pharmacology , Copper/chemistry , Humans , Ligands , Magnetic Resonance Spectroscopy , Manganese/chemistry , Microbial Sensitivity Tests , Molecular Structure , Nickel/chemistry , Piroxicam/chemistry , Piroxicam/pharmacology , Schiff Bases , Spectrophotometry, Infrared , Thermodynamics , Xanthomonas campestris/drug effects , Zinc/chemistry
7.
Article in English | MEDLINE | ID: mdl-31983278

ABSTRACT

The octahedral Ru(II) complexes containing the 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline ligand of type [Ru(N-N)2(L)]2+, where N-N = phen (1,10-phenanthroline) (1), bpy (2,2'-bipyridine) (2), and dmb (4,4'-dimethyl-2,2'-bipyridine) (3); L(dmpip) = (2(2,6-dimethoxypyridine-3-yl)1Himidazo(4,5-f)[1, 10]phenanthroline), have been synthesized and characterized by UV-visible absorption, molar conductivity, elemental analysis, mass, IR, and NMR spectroscopic techniques. The physicochemical properties of the Ru(II) complexes were determined by UV-Vis absorption spectroscopy. The DNA binding studies have been explored by UV-visible absorption, fluorescence titrations, and viscosity measurements. The supercoiled pBR322 DNA cleavage efficiency of Ru(II) complexes 1-3 was investigated. The antimicrobial activity of Ru(II) complexes was done against Gram-positive and Gram-negative microorganisms. The in vitro anticancer activities of all the complexes were investigated by cell viability assay, apoptosis, cellular uptake, mitochondrial membrane potential detection, and semi-quantitative PCR on HeLa cells. The result indicates that the synthesized Ru(II) complexes probably interact with DNA through an intercalation mode of binding with complex 1 having slightly stronger DNA binding affinity and anticancer activity than 2 and 3.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Coordination Complexes/pharmacology , DNA/drug effects , Ruthenium/pharmacology , Animals , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Bacillus megaterium/drug effects , Bacillus megaterium/growth & development , Bacillus subtilis/drug effects , Bacillus subtilis/growth & development , Binding Sites/drug effects , Cattle , Cell Movement/drug effects , Cell Proliferation/drug effects , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , DNA/chemistry , DNA Damage , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Escherichia coli/growth & development , HeLa Cells , Humans , Membrane Potential, Mitochondrial/drug effects , Micrococcus luteus/drug effects , Micrococcus luteus/growth & development , Molecular Structure , Plasmids/drug effects , Ruthenium/chemistry , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Structure-Activity Relationship
8.
PLoS One ; 14(9): e0222528, 2019.
Article in English | MEDLINE | ID: mdl-31545814

ABSTRACT

High Content Analysis (HCA) has become a cornerstone of cellular analysis within the drug discovery industry. To expand the capabilities of HCA, we have applied the same analysis methods, validated in numerous mammalian cell models, to microbiology methodology. Image acquisition and analysis of various microbial samples, ranging from pure cultures to culture mixtures containing up to three different bacterial species, were quantified and identified using various machine learning processes. These HCA techniques allow for faster cell enumeration than standard agar-plating methods, identification of "viable but not plate culturable" microbe phenotype, classification of antibiotic treatment effects, and identification of individual microbial strains in mixed cultures. These methods greatly expand the utility of HCA methods and automate tedious and low-throughput standard microbiological methods.


Subject(s)
Bacteria/metabolism , Machine Learning , Anti-Bacterial Agents/pharmacology , Bacillus megaterium/drug effects , Bacillus megaterium/ultrastructure , Bacteria/chemistry , Bacteria/drug effects , Bacterial Proteins/analysis , Bradyrhizobium/drug effects , Bradyrhizobium/growth & development , Bradyrhizobium/metabolism , Bradyrhizobium/ultrastructure , Colony Count, Microbial , Escherichia coli/drug effects , Escherichia coli/ultrastructure , Pseudomonas fluorescens/drug effects , Pseudomonas fluorescens/ultrastructure
9.
Molecules ; 24(17)2019 Aug 26.
Article in English | MEDLINE | ID: mdl-31454974

ABSTRACT

Piper cubeba L. is the berry of a shrub that is indigenous to Java, Southern Borneo, Sumatra, and other islands in the Indian Ocean. The plant is usually used in folk traditional medicine and is an important ingredient in cooking. The purpose of this study was to isolate and purify the bioactive compounds from P. cubeba L. fractions. In addition, the isolated compounds were tested for their antibacterial and antispore activities against vegetative cells and spores of Bacillus cereus ATCC33019, B. subtilis ATCC6633, B. pumilus ATCC14884, and B. megaterium ATCC14581. The phytochemical investigation of the DCM fraction yielded two known compounds: ß-asarone (1), and asaronaldehyde (2) were successfully isolated and identified from the methanol extract and its fractions of P. cubeba L. Results showed that exposing the vegetative cells of Bacillus sp. to isolated compounds resulted in an inhibition zone with a large diameter ranging between 7.21 to 9.61 mm. The range of the minimum inhibitory concentration (MIC) was between 63.0 to 125.0 µg/mL and had minimum bactericidal concentration (MBC) at 250.0 to 500.0 µg/mL against Bacillus sp. Isolated compounds at a concentration of 0.05% inactivated more than 3-Log10 (90.99%) of the spores of Bacillus sp. after an incubation period of four hours, and all the spores were killed at a concentration of 0.1%. The structures were recognizably elucidated based on 1D and 2D-NMR analyses (1H, 13C, COSY, HSQC, and HMBC) and mass spectrometry data. Compounds 1, and 2 were isolated for the first time from this plant. In conclusion, the two compounds show a promising potential of antibacterial and sporicidal activities against Bacillus sp. and thus can be developed as an anti-Bacillus agent.


Subject(s)
Aldehydes/pharmacology , Anisoles/pharmacology , Anti-Bacterial Agents/pharmacology , Piper/chemistry , Spores, Bacterial/drug effects , Aldehydes/isolation & purification , Allylbenzene Derivatives , Anisoles/isolation & purification , Anti-Bacterial Agents/isolation & purification , Bacillus cereus/drug effects , Bacillus cereus/physiology , Bacillus megaterium/chemistry , Bacillus megaterium/drug effects , Bacillus pumilus/drug effects , Bacillus pumilus/physiology , Bacillus subtilis/drug effects , Bacillus subtilis/physiology , Chromatography, Thin Layer , Medicine, Traditional , Microbial Sensitivity Tests , Molecular Structure , Plant Extracts/isolation & purification , Plant Extracts/pharmacology
10.
Sci Rep ; 9(1): 12082, 2019 08 19.
Article in English | MEDLINE | ID: mdl-31427655

ABSTRACT

Endogenous reactive oxygen species (ROS) are by-products of the aerobic metabolism of cells and have an important signalling role as secondary messengers in various physiological processes, including cell growth and development. However, the excessive production of ROS, as well as the exposure to exogenous ROS, can cause protein oxidation, lipid peroxidation and DNA damages leading to cell injuries. ROS accumulation has been associated to the development of health disorders such as neurodegenerative and cardiovascular diseases, inflammatory bowel disease and cancer. We report that spores of strain SF185, a human isolate of Bacillus megaterium, have antioxidant activity on Caco-2 cells exposed to hydrogen peroxide and on a murine model of dextran sodium sulfate-induced oxidative stress. In both model systems spores exert a protective state due to their scavenging action: on cells, spores reduce the amount of intracellular ROS, while in vivo the pre-treatment with spores protects mice from the chemically-induced damages. Overall, our results suggest that treatment with SF185 spores prevents or reduces the damages caused by oxidative stress. The human origin of SF185, its strong antioxidant activity, and its protective effects led to propose the spore of this strain as a new probiotic for gut health.


Subject(s)
Bacillus megaterium/metabolism , DNA Damage/drug effects , Oxidative Stress/drug effects , Spores, Bacterial/chemistry , Animals , Bacillus megaterium/drug effects , Caco-2 Cells , Dextran Sulfate/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Lipid Peroxidation/drug effects , Mice , Oxidation-Reduction/drug effects , Reactive Oxygen Species/metabolism , Spores, Bacterial/drug effects , Spores, Bacterial/metabolism
11.
J Appl Microbiol ; 126(5): 1391-1401, 2019 May.
Article in English | MEDLINE | ID: mdl-30828950

ABSTRACT

AIMS: To investigate effects of the cationic surfactant cetyltrimethylammonium bromide (CTAB), a disinfectant, on spores of Bacillus species. METHODS AND RESULTS: The ability of CTAB to trigger release of Bacillus spores' large depot of dipicolinic acid (DPA) in a 1 : 1 chelate with Ca2+ (CaDPA), and to kill spores was investigated. CTAB-triggered CaDPA release from spores of Bacillus subtilis, Bacillus cereus and Bacillus megaterium, but was not followed by completion of germination. CaDPA release triggered by CTAB increased at higher temperatures, and was optimal for B. subtilis spores at pH 9·4 and 30 µg ml-1 CTAB. CTAB also killed Bacillus spores as shown by plate counts and vital staining of treated dormant spores, and after their germination. However, B. cereus and B. megaterium spores were more CTAB-sensitive than were B. subtilis spores. CaDPA release from and killing of CTAB-treated spores of isogenic B. subtilis mutants lacking germination proteins was also examined, and compared with effects of the well-known germinant dodecylamine on spores, to determine how CTAB exerts its effects on spores. CONCLUSIONS: The results of this investigation showed that CTAB kills spores of three Bacillus species, perhaps by damaging the spore inner membrane, although it is also possible that some killing by this agent follows its triggering of spore germination. SIGNIFICANCE AND IMPACT OF THE STUDY: The results of this work indicate that CTAB is also a disinfectant, but also a sporicide, and may be a useful adjunct in spore decontamination, especially at higher temperatures.


Subject(s)
Bacillus/drug effects , Cetrimonium/pharmacology , Disinfectants/pharmacology , Amines/pharmacology , Bacillus cereus/drug effects , Bacillus megaterium/drug effects , Bacillus subtilis/drug effects , Decontamination , Hot Temperature , Picolinic Acids/analysis , Spores, Bacterial/chemistry , Spores, Bacterial/drug effects , Surface-Active Agents/metabolism
12.
Mar Drugs ; 17(3)2019 Mar 08.
Article in English | MEDLINE | ID: mdl-30857135

ABSTRACT

Sponges are a well-known bioresource for bioactive compounds. In this study, antibacterial activity-guided fractionation of the extract from an Indonesian marine Dactylospongia elegans sponge led to the discovery of four merosesquiterpenoids, namely, a new sesquiterpenoid aminoquinone nakijiquinone V (1), along with illimaquinone (2), smenospongine (3), and dyctioceratine C (4). The structure of compound 1 was elucidated by 1D and 2D NMR as well as by LC-HRESIMS data analysis. Compounds 2⁻4 showed moderate to low antimicrobial activity against Bacillus megaterium DSM32 with a minimum inhibitory concentration (MIC) of 32 µg/mL, 32 µg/mL, and 64 µg/mL, respectively. Furthermore, compounds 2 and 3 both inhibited Micrococcus luteus ATCC 4698 with a MIC of 32 µg/mL. In conclusion, the isolated merosesquiterpenoids, which are known for their cytotoxic effects, showed antibacterial activity and prompt future structure activity relationship (SAR) studies concerning the various bioactivities observed for this group of natural products.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biological Products/pharmacology , Porifera/chemistry , Quinones/pharmacology , Sesquiterpenes/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Bacillus megaterium/drug effects , Biological Products/isolation & purification , Indonesia , Microbial Sensitivity Tests , Micrococcus luteus/drug effects , Molecular Structure , Quinones/chemistry , Quinones/isolation & purification , Sesquiterpenes/chemistry , Sesquiterpenes/isolation & purification
13.
Article in English | MEDLINE | ID: mdl-30755080

ABSTRACT

Spent catalysts represent an environmental concern, mainly due to their elevated metal content. Although conventional treatment methods for spent catalysts are available, they generate large volumes of potentially harmful wastes and gaseous emissions. To overcome the environmental impact, biotechnological approaches are currently being explored and developed. Thus, the current study assayed the capability of Bacillus megaterium strain MNSH1-9K-1 to remove Al, Ni, V and Ti contained in the spent catalyst coded as ECAT-TL-II. To this end, B. megaterium MNSH1-9K-1 growth and metal uptake abilities in the presence of ECAT-TL-II spent catalyst at 15% (wt/vol) pulp density were evaluated in modified Starkey medium at 37 °C and 200 rpm. The results presented here show B. megaterium resistance capability to the high-metal content residue, and its Al, V and Ni removal ability, in 1,059.15 ± 197.28 mg kg-1 of Al, 43.39 ± 24.13 mg kg-1 of V and 0.58 ± 0.00 mg kg-1 of Ni, corresponding to the 0.79%, 1.63% and 0.46% of each metal content, respectively, while no Ti removal was detected. Besides, it was observed that the sporulation process took place in B. megaterium cells in the presence of the spent catalyst. The results shown in this study suggest the potential of the strain MNSH1-9K-1 for the removal of metals contained in high-metal content residues, contributing also to the knowledge of the metal resistance and removal abilities of B. megaterium in the presence of a spent catalyst, and how morphological cell changes may be occurring while metal removal is taking place.


Subject(s)
Bacillus megaterium/drug effects , Environmental Pollutants/analysis , Industrial Waste/analysis , Metals/analysis , Oil and Gas Industry , Spores, Bacterial/drug effects , Bacillus megaterium/growth & development , Bacillus megaterium/physiology , Biodegradation, Environmental , Catalysis , Microbial Viability/drug effects , Models, Theoretical , Spores, Bacterial/growth & development , Spores, Bacterial/physiology
14.
Bioorg Med Chem ; 27(5): 777-784, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30692023

ABSTRACT

A simple and one-pot approach for the synthesis of highly functionalized novel (E)-2-benzylideno-(Z)-carbazolylideno cyanoacetamide derivatives from different 2-(2',3',4',9'-tetrahydro-carbazol-1'-ylidene)-propanedinitriles and aryl/heteroaryl carbaldehydes via vinylogous aldol reaction. The structures of the molecules were designated by FT-IR, 1H NMR, 13C NMR studies, elemental and X-ray crystallographic analysis. The synthesized pure products have been screened for in vitro antibiofilm inhibitory activity towards antibiotic-resistant pathogenic organisms. All the synthesized compounds showed biofilm inhibition. Promisingly, the moieties 3a, 3d and 3h showed higher antibiofilm activity at biofilm inhibitory concentration (BIC) (200 µg/mL) against bacterial pathogens. Among the three moieties, 3a showed high prospective against E. coli biofilm with minimal and maximal BIC percentage of 32% (10 µg/mL) and 89% (100 µg/mL) and chosen lowest BIC for further evaluation. Also, the 3a generate ROS two fold at 1 h treatment in E. coli biofilm. The 3a exhibited no toxic effect on cell viability upto 75 µg/mL in HEK293 cell lines. The results of the present study reveal that among (E)-2-benzylideno-(Z)-carbazolylideno cyanoacetamides, (E)-2-benzylideno-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-(Z)-α-carbamino-α-cyano-1-ylidene (3a) could be exploited as an excellent antibiofilm agent against carbapenem-resistant E. coli bacteria strains.


Subject(s)
Acetamides/pharmacology , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Carbazoles/pharmacology , Acetamides/chemical synthesis , Acetamides/toxicity , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/toxicity , Bacillus megaterium/drug effects , Bacillus subtilis/drug effects , Carbazoles/chemical synthesis , Carbazoles/toxicity , Gram-Negative Bacteria/drug effects , HEK293 Cells , Humans , Microbial Sensitivity Tests , Molecular Structure , Structure-Activity Relationship
15.
Anim Biotechnol ; 30(2): 151-158, 2019 Apr.
Article in English | MEDLINE | ID: mdl-29592658

ABSTRACT

The extent of subclinical mastitis in three breeds of cattle, Kankrej, Gir, and Crossbred, was performed at cattle farms in Anand town of Gujarat State, India. The prevalence of subclinical mastitis in crossbred cattle was higher compared to local breed of cattle. Causative agents identified using 16S rDNA polymerase chain reaction (PCR)-based molecular method were Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Bacillus megaterium. In vitro antibacterial activity of ethyl acetate extract of plant Terminalia chebula (Combretaceae) was checked by agar well diffusion method against four isolated and molecularly identified microorganisms. Ethyl acetate extract shows antimicrobial activity with varying magnitudes against all identified isolates. Among the three different concentrations, 500 µg/mL conc. of extract is as effective as that of standard amoxicillin. In vitro results support the use of plant extract from T. chebula as an alternative to antibiotics therapy against bovine subclinical mastitis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Mastitis, Bovine/drug therapy , Plant Extracts/pharmacology , Terminalia/chemistry , Animals , Bacillus megaterium/drug effects , Cattle , Escherichia coli/drug effects , Female , Mastitis, Bovine/microbiology , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects
16.
J Trace Elem Med Biol ; 51: 219-225, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29735327

ABSTRACT

With the threat of the growing number of bacteria resistant to antibiotics, the re-emergence of previously deadly infections and the emergence of new infections, there is an urgent need for novel therapeutic agent. Silver in the nano form, which is being used increasingly as antibacterial agents, may extend its antibacterial application to emerging and re-emerging multidrug-resistant pathogens, the main cause of nosocomial diseases worldwide. In the present study, a completely bottom up method to prepare green nano-silver was used. To explore the action of nano-silver on emerging Bacillus megaterium MTCC 7192 and re-emerging Pseudomonas aeruginosa MTCC 741 pathogenic bacteria, the study includes an analysis of the bacterial membrane damage through Scanning Electron Microscope (SEM) as well as alternation of zeta potential and intracellular leakages. In this work, we observed genuine bactericidal property of nano-silver as compare to broad spectrum antibiotics against emerging and re-emerging mode. After being exposed to nano-silver, the membrane becomes scattered from their original ordered arrangement based on SEM observation. Moreover, our results also suggested that alternation of zeta potential enhanced membrane permeability, and beyond a critical point, it leads to cell death. The leakages of intracellular constituents were confirmed by Gas Chromatography-Mass Spectrometry (GC-MS). In conclusion, the combine results suggested that at a specific dose, nano-silver may destroy the structure of bacterial membrane and depress its activity, which causes bacteria to die eventually.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillus megaterium/drug effects , Metal Nanoparticles/chemistry , Pseudomonas aeruginosa/drug effects , Silver/pharmacology , Anti-Bacterial Agents/chemistry , Gas Chromatography-Mass Spectrometry , Humans , Microbial Sensitivity Tests , Silver/chemistry
17.
Appl Microbiol Biotechnol ; 103(1): 303-313, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30392122

ABSTRACT

A novel inducible gene expression system using p-isopropyl benzoate (cumate) as an inducer was developed for the industrial production hosts, Bacillus subtilis and Bacillus megaterium. Cumate is non-toxic to the host, inexpensive, and carbon source-independent inducer which provides an economical option for large-scale production of valuable proteins and chemicals from Bacillus strains. The synthetic cumate-inducible system was constructed by combining the strong constitutive Bacillus promoter Pveg with regulatory elements of the Pseudomonas putida, CymR repressor, and its operator sequence CuO. The designed expression cassette containing a sfGFP reporter under the cumate-inducible promoter was assembled into a Bacillus-E. coli shuttle and gene expression investigated in the two Bacillus strains. Characterization of gene expression levels, expression kinetics, and dose-response to cumate inducer concentration confirmed high-level, but tightly controlled GFP reporter expression in tunable, cumate concentration-dependent manner. Unexpectedly, this expression system works equally well for Escherichia coli, resulting in a platform that can be used both in gram-positive and gram-negative expression host. Its tight regulation and controllable expression makes this system useful for metabolic engineering, synthetic biology studies as well industrial protein production.


Subject(s)
Bacillus megaterium/genetics , Bacillus subtilis/genetics , Benzoates/pharmacology , Gene Expression Regulation, Bacterial/drug effects , Genetic Engineering/methods , Bacillus megaterium/drug effects , Bacillus subtilis/drug effects , Benzoates/administration & dosage , Escherichia coli/genetics , Gene Expression Profiling , Genetic Vectors , Green Fluorescent Proteins/genetics , Microorganisms, Genetically-Modified , Plasmids/genetics , Promoter Regions, Genetic , Pseudomonas putida/genetics , Regulatory Sequences, Nucleic Acid
18.
Chemosphere ; 216: 258-270, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30384294

ABSTRACT

The current study describes biological changes in Bacillus megaterium A14K cells growing in the presence of 2,3,7,8-Tetrachlorinated dibenzo-p-dioxin (TCDD), the most potent congener of dioxins. The results indicate that the metabolizing of 2,3,7,8-TCDD by BmA14K was accompanied with a novel morphological and biophysical profile typified by the growth of single cells with high levels of biosurfactant production, surface hydrophobicity and cell membrane permeability. Moreover, the TCDD-grown bacteria exhibited a specific fatty acid profile characterized by low ratios of branched/straight chain fatty acids (BCFAs/SCFAs) and saturated/unsaturated fatty acids (SFAs/USFAs) with a specific "signature" due to the presence of branched chain unsaturated fatty acids (BCUFAs). This was synchronized with a significant induction of P450BM-1, an unsaturated fatty acid-metabolizing enzyme in B. megaterium. Subsequently, the profile of oxygenated fatty acids in the TCDD-grown bacteria was typified by the presence of 5,6-epoxy derived from unsaturated C15, C16 and C17 fatty acids, that were absent in control bacteria. A net increase was also detected in both hydroxylated and epoxidized fatty acids, especially those derived from C15:0 and C16:1, respectively, suggesting a specific TCDD-induced "signature" of oxygenated fatty acids in BmA14K. Overall, this study sheds light on the use of B. megaterium A14K as a promising bioindicator/biodegrader of dioxins.


Subject(s)
Bacillus megaterium/metabolism , Cytochrome P-450 Enzyme System/metabolism , Environmental Pollutants/pharmacology , Fatty Acids/analysis , Gene Expression Regulation, Enzymologic/drug effects , Polychlorinated Dibenzodioxins/pharmacology , Bacillus megaterium/drug effects , Bacillus megaterium/growth & development , Cytochrome P-450 Enzyme System/drug effects , Fatty Acids/metabolism
19.
Sci Rep ; 8(1): 16105, 2018 10 31.
Article in English | MEDLINE | ID: mdl-30382109

ABSTRACT

RNA-seq analysis of B. megaterium exposed to pH 7.0 and pH 4.5 showed differential expression of 207 genes related to several processes. Among the 207 genes, 11 genes displayed increased transcription exclusively in pH 4.5. Exposure to pH 4.5 induced the expression of genes related to maintenance of cell integrity, pH homeostasis, alternative energy generation and modification of metabolic processes. Metabolic processes like pentose phosphate pathway, fatty acid biosynthesis, cysteine and methionine metabolism and synthesis of arginine and proline were remodeled during acid stress. Genes associated with oxidative stress and osmotic stress were up-regulated at pH 4.5 indicating a link between acid stress and other stresses. Acid stress also induced expression of genes that encoded general stress-responsive proteins as well as several hypothetical proteins. Our study indicates that a network of genes aid B. megaterium G18 to adapt and survive in acid stress condition.


Subject(s)
Acids/toxicity , Adaptation, Physiological/genetics , Bacillus megaterium/genetics , Gene Expression Profiling , Gene Regulatory Networks/drug effects , Genome, Bacterial , Stress, Physiological/genetics , Adaptation, Physiological/drug effects , Bacillus megaterium/drug effects , Bacillus megaterium/growth & development , Gene Expression Regulation, Bacterial/drug effects , Hydrogen-Ion Concentration , Molecular Sequence Annotation , Stress, Physiological/drug effects , Transcriptome/genetics
20.
Article in English | MEDLINE | ID: mdl-29662839

ABSTRACT

Due to their archaic life style and microbivor behavior, amoebae may represent a source of antimicrobial peptides and proteins. The amoebic protozoon Dictyostelium discoideum has been a model organism in cell biology for decades and has recently also been used for research on host-pathogen interactions and the evolution of innate immunity. In the genome of D. discoideum, genes can be identified that potentially allow the synthesis of a variety of antimicrobial proteins. However, at the protein level only very few antimicrobial proteins have been characterized that may interact directly with bacteria and help in fighting infection of D. discoideum with potential pathogens. Here, we focus on a large group of gene products that structurally belong to the saposin-like protein (SAPLIP) family and which members we named provisionally Apls (amoebapore-like peptides) according to their similarity to a comprehensively studied antimicrobial and cytotoxic pore-forming protein of the protozoan parasite Entamoeba histolytica. We focused on AplD because it is the only Apl gene that is reported to be primarily transcribed further during the multicellular stages such as the mobile slug stage. Upon knock-out (KO) of the gene, aplD- slugs became highly vulnerable to virulent Klebsiella pneumoniae. AplD- slugs harbored bacterial clumps in their interior and were unable to slough off the pathogen in their slime sheath. Re-expression of AplD in aplD- slugs rescued the susceptibility toward K. pneumoniae. The purified recombinant protein rAplD formed pores in liposomes and was also capable of permeabilizing the membrane of live Bacillus megaterium. We propose that the multifarious Apl family of D. discoideum comprises antimicrobial effector polypeptides that are instrumental to interact with bacteria and their phospholipid membranes. The variety of its members would allow a complementary and synergistic action against a variety of microbes, which the amoeba encounters in its environment.


Subject(s)
Bacterial Infections/immunology , Dictyostelium/immunology , Dictyostelium/microbiology , Host-Pathogen Interactions/immunology , Immunity, Innate , Saposins/metabolism , Saposins/pharmacology , Animals , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Bacillus megaterium/drug effects , Dictyostelium/genetics , Dictyostelium/metabolism , Gastropoda/immunology , Gastropoda/metabolism , Gastropoda/microbiology , Gene Expression Profiling , Ion Channels/metabolism , Ion Channels/pharmacology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/pathogenicity , Liposomes/metabolism , Peptides/genetics , Peptides/metabolism , Peptides/pharmacology , Protozoan Proteins/metabolism , Protozoan Proteins/pharmacology , Recombinant Proteins , Saposins/genetics , Saposins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...